Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors. [electronic resource]
Producer: 20160726Description: 875-83 p. digitalISSN:- 1097-0142
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Disease-Free Survival
- ErbB Receptors -- genetics
- Female
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Mammalian orthoreovirus 3
- Middle Aged
- Neoplasm Grading
- Neoplasm Recurrence, Local -- drug therapy
- Oncolytic Virotherapy -- methods
- Proto-Oncogene Proteins p21(ras) -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.